174 related articles for article (PubMed ID: 36231010)
1. Thyroid Hormone Induces Oral Cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells.
Chen YR; Chen YS; Chin YT; Li ZL; Shih YJ; Yang YSH; ChangOu CA; Su PY; Wang SH; Wu YH; Chiu HC; Lee SY; Liu LF; Whang-Peng J; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2019 Oct; 132():110693. PubMed ID: 31336132
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells.
Chin YT; Wei PL; Ho Y; Nana AW; Changou CA; Chen YR; Yang YS; Hsieh MT; Hercbergs A; Davis PJ; Shih YJ; Lin HY
Endocr Relat Cancer; 2018 May; 25(5):533-545. PubMed ID: 29555649
[TBL] [Abstract][Full Text] [Related]
4. Actions of l-thyroxine and Nano-diamino-tetrac (Nanotetrac) on PD-L1 in cancer cells.
Lin HY; Chin YT; Nana AW; Shih YJ; Lai HY; Tang HY; Leinung M; Mousa SA; Davis PJ
Steroids; 2016 Oct; 114():59-67. PubMed ID: 27221508
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells.
Hsieh MT; Wang LM; Changou CA; Chin YT; Yang YSH; Lai HY; Lee SY; Yang YN; Whang-Peng J; Liu LF; Lin HY; Mousa SA; Davis PJ
Oncotarget; 2017 Apr; 8(15):24237-24249. PubMed ID: 27458161
[TBL] [Abstract][Full Text] [Related]
6. Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells.
Lin SJ; Chin YT; Ho Y; Chou SY; Sh Yang YC; Nana AW; Su KW; Lim YT; Wang K; Lee SY; Shih YJ; Chen YR; Whang-Peng J; Davis PJ; Lin HY; Fu E
Food Chem Toxicol; 2018 Oct; 120():1-11. PubMed ID: 29960019
[TBL] [Abstract][Full Text] [Related]
7. Role of Integrin αvβ3 in Doxycycline-Induced Anti-Proliferation in Breast Cancer Cells.
Chen YF; Yang YN; Chu HR; Huang TY; Wang SH; Chen HY; Li ZL; Yang YSH; Lin HY; Hercbergs A; Whang-Peng J; Wang K; Davis PJ
Front Cell Dev Biol; 2022; 10():829788. PubMed ID: 35237605
[TBL] [Abstract][Full Text] [Related]
8. Crosstalk between integrin αvβ3 and estrogen receptor-α is involved in thyroid hormone-induced proliferation in human lung carcinoma cells.
Meng R; Tang HY; Westfall J; London D; Cao JH; Mousa SA; Luidens M; Hercbergs A; Davis FB; Davis PJ; Lin HY
PLoS One; 2011; 6(11):e27547. PubMed ID: 22132110
[TBL] [Abstract][Full Text] [Related]
9. Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone.
Lin HY; Su YF; Hsieh MT; Lin S; Meng R; London D; Lin C; Tang HY; Hwang J; Davis FB; Mousa SA; Davis PJ
FASEB J; 2013 Aug; 27(8):3209-16. PubMed ID: 23640055
[TBL] [Abstract][Full Text] [Related]
10. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
[TBL] [Abstract][Full Text] [Related]
11. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells.
Ho Y; Wu CY; Chin YT; Li ZL; Pan YS; Huang TY; Su PY; Lee SY; Crawford DR; Su KW; Chiu HC; Shih YJ; Changou CA; Yang YSH; Whang-Peng J; Chen YR; Lin HY; Mousa SA; Davis PJ; Wang K
Food Chem Toxicol; 2020 Feb; 136():111092. PubMed ID: 31883986
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of STAT3/PD-L1 and Activation of miR193a-5p Are Critically Involved in Apoptotic Effect of Compound K in Prostate Cancer Cells.
Lee JH; Lee DY; Lee HJ; Im E; Sim DY; Park JE; Park WY; Shim BS; Kim SH
Cells; 2021 Aug; 10(8):. PubMed ID: 34440920
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway.
Ren D; Zhao J; Sun Y; Li D; Meng Z; Wang B; Fan P; Liu Z; Jin X; Wu H
J Exp Clin Cancer Res; 2019 Dec; 38(1):485. PubMed ID: 31818309
[TBL] [Abstract][Full Text] [Related]
14. Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.
Cao D; Qi Z; Pang Y; Li H; Xie H; Wu J; Huang Y; Zhu Y; Shen Y; Zhu Y; Dai B; Hu X; Ye D; Wang Z
Cancer Res; 2019 May; 79(10):2604-2618. PubMed ID: 30808674
[TBL] [Abstract][Full Text] [Related]
15. Anticancer Activities of Hesperidin via Suppression of Up-Regulated Programmed Death-Ligand 1 Expression in Oral Cancer Cells.
Wudtiwai B; Makeudom A; Krisanaprakornkit S; Pothacharoen P; Kongtawelert P
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500779
[TBL] [Abstract][Full Text] [Related]
16. Actions of Thyroid Hormones on Thyroid Cancers.
Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
[TBL] [Abstract][Full Text] [Related]
17. L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Lin HY; Sun M; Tang HY; Lin C; Luidens MK; Mousa SA; Incerpi S; Drusano GL; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2009 May; 296(5):C980-91. PubMed ID: 19158403
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
[TBL] [Abstract][Full Text] [Related]
20. Shikonin-mediated PD-L1 degradation suppresses immune evasion in pancreatic cancer by inhibiting NF-κB/STAT3 and NF-κB/CSN5 signaling pathways.
Ruan Z; Liang M; Shang L; Lai M; Deng X; Su X
Pancreatology; 2021 Apr; 21(3):630-641. PubMed ID: 33707115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
